(DOWNLOAD) "Methdadone Use in Relation to Hepatitis C Virus Testing in British Columbia (Quantitative Research) (Report)" by Canadian Journal of Public Health # eBook PDF Kindle ePub Free
eBook details
- Title: Methdadone Use in Relation to Hepatitis C Virus Testing in British Columbia (Quantitative Research) (Report)
- Author : Canadian Journal of Public Health
- Release Date : January 01, 2010
- Genre: Law,Books,Professional & Technical,
- Pages : * pages
- Size : 278 KB
Description
Hepatitis C virus (HCV) infection is highly prevalent among persons who inject drugs (IDU) as well as patients receiving methadone maintenance treatment (MMT). Seroprevalence rates for antibody to HCV (anti-HCV) range from 27-96% among IDU populations and 67-96% in patients in MMT programs. (1) In British Columbia (BC), HCV seroprevalence among subjects of a longitudinal cohort study, in an inner city neighbourhood characterized by poverty, mental illness and drug use, was estimated at 10% in 1992 and 90% by 2004, based on laboratory data linkage. (2,3) Drug injection duration is clearly important, with up to half of new injectors acquiring HCV infection within the first 4 years and greater than 90% after a decade or more of injecting. (1,4,5) MMT has been shown to be effective in the treatment of opiate substance dependence such as addiction to heroin and morphine. Studies have found that among opiate-dependent patients, sustained MMT reduces morbidity and mortality, diminishes involvement in crime (6,7) and helps drug users to gain control of their lives. (8)